Accuracy of core biopsy in predicting pathologic complete response in the breast in patients with complete/near complete clinical and radiological response (Complete Responders in the Breast – CRBr) – Trial design and conduct

INTRODUCTION: With the advent of taxanes and targeted agents in neoadjuvant chemotherapy (NACT) for breast cancer, the rates of pathologic complete response (pCR) have been steadily increasing. One of the roles of surgery in these women is to serve as a biopsy to confirm or negate a pCR. DESIGN: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hariharan, N., Rao, T.S., Rajappa, S., Naidu, C.C.K., Raju, K.V.V.N., Koppula, V., Murthy, S., Kodandapani, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921145/
https://www.ncbi.nlm.nih.gov/pubmed/31897442
http://dx.doi.org/10.1016/j.isjp.2019.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921145/
https://www.ncbi.nlm.nih.gov/pubmed/31897442
http://dx.doi.org/10.1016/j.isjp.2019.05.002

Ejemplares similares